Posted by Michael Wonder on 25 Sep 2024
Moderna receives Health Canada approval for updated COVID-19 vaccine targeting KP.2 variant of SARS-COV-2 for ages six months and older
17 September 2024 - Spikevax is the first updated COVID-19 vaccine authorised in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season.
Moderna today announced that Health Canada has authorised its updated COVID-19 vaccine, Spikevax KP.2 variant, to help prevent COVID-19 in individuals six months of age and older.
